INHIBITION BY PROBUCOL OF INTERLEUKIN-1 SECRETION AND ITS IMPLICATION IN ATHEROSCLEROSIS

被引:83
作者
KU, G
DOHERTY, NS
WOLOS, JA
JACKSON, RL
SCHMIDT, LF
HENDRICKS, D
机构
关键词
D O I
10.1016/S0002-9149(88)80057-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:B77 / B81
页数:5
相关论文
共 15 条
[1]  
ADAM A, 1985, MODERN CONCEPTS IMMU, V1
[2]   OVERVIEW OF BIOCHEMICAL PHARMACOLOGY OF PROBUCOL [J].
BARNHART, JW ;
RYTTER, DJ ;
MOLELLO, JA .
LIPIDS, 1977, 12 (01) :29-33
[3]   THE SCAVENGER CELL PATHWAY FOR LIPOPROTEIN DEGRADATION - SPECIFICITY OF THE BINDING-SITE THAT MEDIATES THE UPTAKE OF NEGATIVELY-CHARGED LDL BY MACROPHAGES [J].
BROWN, MS ;
BASU, SK ;
FALCK, JR ;
HO, YK ;
GOLDSTEIN, JL .
JOURNAL OF SUPRAMOLECULAR STRUCTURE, 1980, 13 (01) :67-81
[5]   CHARACTERIZATION OF A LEUKOCYTE-DERIVED ENDOGENOUS MEDIATOR RESPONSIBLE FOR INCREASED PLASMA-FIBRINOGEN [J].
KAMPSCHMIDT, RF ;
UPCHURCH, HF ;
PULLIAM, LA .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1982, 389 (JUN) :338-353
[6]   TOXICITY OF OXIDIZED LOW-DENSITY-LIPOPROTEIN TO CULTURED FIBROBLASTS IS SELECTIVE FOR S-PHASE OF THE CELL-CYCLE [J].
KOSUGI, K ;
MOREL, DW ;
DICORLETO, PE ;
CHISOLM, GM .
JOURNAL OF CELLULAR PHYSIOLOGY, 1987, 130 (03) :311-320
[7]  
LIBBY P, 1987, FASEB J, V46, P975
[8]  
MIZEL SB, 1978, J IMMUNOL, V120, P1497
[9]  
MURPHY PA, 1980, J IMMUNOL, V124, P2498
[10]  
NEILSON KB, 1985, J BIOL CHEM, V258, P13063